University of Illinois at Chicago

South Shore clinic expands COVID-19 testing

UI Health Mile Square Health Center now testing community members for COVID-19

Newswise — UI Health Mile Square Health Center — a network of federally qualified health centers, or FQHCs, in Chicago — is now providing COVID-19 testing to community members on the South Side who meet testing criteria at its South Shore clinic, located at 7037 S. Stony Island Ave.

Previously, only established or new Mile Square patients with symptoms were able to get a test. Now, any person in the community who meets testing criteria, such as having symptoms of fever, cough, shortness of breath and diarrhea, can make an appointment to get tested. Test results will be available in one to two days.

“We are proud to respond to the needs of the South Shore community and to play an active role in addressing COVID-19 disparities,” said Dr. Ian Jasenof, chief medical officer of UI Health Mile Square Health Center.

“Mile Square has a long history of bringing health care to communities regardless of individuals’ income, insurance status or ability to pay for care — expanding our COVID-19 testing capacity on Chicago’s South Side is an extension of our promise to put the health and well-being of all communities at the center of all we do,” said Henry Taylor, executive director of the UI Health Mile Square network.

The South Shore clinic began testing a limited number of patients today but will test patients, by appointment, 10 a.m to 3 p.m., Monday through Friday, starting tomorrow. The clinic is prepared to provide up to 30 tests a day.

As part of its expanded testing program, Mile Square has formalized a home monitoring program for individuals who test positive.

“Follow up and monitoring COVID-19 progression is just as important as testing,” Jasenof said. “We still do not know why some people with COVID-19 have mild illness while others have severe and life-threatening illness. This monitoring process was developed to make sure that if people do become severely ill, they have resources in place to get help quickly.”

The South Shore clinic occupies space owned and operated by the Chicago Child Care Society, in Chicago’s 5th Ward.

“I welcome Mile Square’s capacity to start testing in Shore Shore, which is one of the communities hardest hit by the pandemic. While 30 tests per day are a good first start, I hope the staff will have the resources to increase the number of daily tests,” said 5th Ward Ald. Leslie Hairston. “We know the key to flattening the curve is treatment, testing and tracking.”

Dara Munson, CEO of the Chicago Childcare Society, said, “Chicago Child Care Society has a long-standing commitment to the South Shore neighborhood and is a proud partner with UI Mile Square Health Center. We are saddened but not surprised by the disparities that COVID-19 is illuminating. CCCS is committed to doing our part to serve this and all communities during this pandemic and beyond.”

The South Shore clinic is the third official testing site in the University of Illinois Hospital and Health Sciences System, which is part of the University of Illinois at Chicago. The UI Health Mile Square drive-up testing center, located at 1220 S. Wood St., tested its first patient on March 25, and the Pilsen COVID-19 evaluation clinic, located at 1713 S. Ashland Ave., began evaluating and testing patients on March 30.

Combined, these three UI Health testing centers can process around 150 tests each day.

At this time, all testing centers are by appointment only and only for patients who meet testing criteria.

Patients should call 866-600-2273 to speak with a nurse to make an appointment or visit hospital.uillinois.edu for more information.

Mile Square plans to expand its COVID-19 testing program to other locations as well. Next up is its clinic in Cicero, located at 4745–51 W. Cermak Road. Testing at this clinic is expected to start in early May.




Filters close

Showing results

110 of 3821
Newswise: UC Davis Health announces Post-COVID-19 Clinic for long-haul patients
Released: 28-Oct-2020 5:20 PM EDT
UC Davis Health announces Post-COVID-19 Clinic for long-haul patients
UC Davis Health

UC Davis Health is one of only a handful of health systems in the U.S. to launch a Post-COVID-19 Clinic to care for long-haul COVID patients whose symptoms go on and on, sometimes for months, with no clear explanation or avenue for treatment.

Newswise: Most People Mount a Strong Antibody Response to 
SARS-CoV-2 That Does Not Decline Rapidly
Released: 28-Oct-2020 5:20 PM EDT
Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly
Mount Sinai Health System

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.

Newswise: 45a1c2a0-c0a4-11ea-b53e-cb3f2ed770b1.jpg
Released: 28-Oct-2020 4:00 PM EDT
Investigator on the AtraZeneca vaccine trial will take questions at Live Event on Oct. 29, 3PM
Keck Medicine of USC

Dr. Edward Jones-Lopez, joins a Newswise Live Expert Panel on Thursday Oct. 29, from 3-4 PM EDT to discuss the AstraZenea COVID-19 vaccine trial.

Released: 28-Oct-2020 4:00 PM EDT
"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT
Newswise

"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT

Newswise: Oak Ridge National Laboratory industry collaboration enables job growth, N95 mask production in Florida
Released: 28-Oct-2020 2:15 PM EDT
Oak Ridge National Laboratory industry collaboration enables job growth, N95 mask production in Florida
Oak Ridge National Laboratory

A collaboration between the Department of Energy’s Oak Ridge National Laboratory and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.

Released: 28-Oct-2020 1:55 PM EDT
What EEGs tell us about COVID-19 and the brain
Baylor College of Medicine

Throughout the pandemic, healthcare workers have seen more than just the lungs affected by COVID-19. Doctors have reported neurological complications including stroke, headache and seizures, but the information is limited to a number of individual reports that are not reflective of a larger population.

Released: 28-Oct-2020 1:50 PM EDT
A new playbook: COVID-19, athletes' hearts and return to play
Massachusetts General Hospital

Reports have indicated that COVID-19 may cause heart damage in hospitalized patients with severe cases of the disease, but it's unclear whether cardiac injury also occurs in infected patients who are asymptomatic or experience only mild symptoms.

Newswise: 0815UCI20052-1069-768x512.jpg
Released: 28-Oct-2020 1:05 PM EDT
Antibody screening finds COVID-19 nearly 7 times more prevalent in O.C. than thought
University of California, Irvine

Irvine, Calif., Oct. 28, 2020 — Testing a representative sample of Orange County residents for a wide range of coronavirus antibodies, University of California, Irvine researchers found that 11.5 percent of them have antibodies for COVID-19, in contrast to previous estimates of less than 2 percent. Latino and low-income residents had the highest prevalence of SARS-CoV-02 antibodies with rates of 17 percent and 15 percent, respectively.

Released: 28-Oct-2020 1:05 PM EDT
Researchers find confusion over masks for wildfire, COVID-19 crises
Stanford School of Earth, Energy & Environmental Sciences

To mask or not to mask - and which mask to use? With public health guidance about masks in the United States confused by political hedging, clarity around mask use is increasingly important, especially as the western U.S. battles the twin crises of wildfire smoke and COVID-19.


Showing results

110 of 3821

close
0.9712